Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer
Langenbeck's Archives of Surgery · 2024
DOI: 10.1007/s00423-024-03233-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Langenbeck's Archives of Surgery, 2024. Verfasst von Tatsuaki Sumiyoshi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hiroshima University.
Abstract (Originalsprache)
Purpose
To elucidate the clinical significance of peritoneal washing cytology (PWC) in patients with resectable biliary tract cancer (BTC).
Methods
Clinical data of patients with BTC, who received PWC at curative intent surgery from March 2009 to December 2021, were retrospectively analyzed. Eligible patients were stratified into two groups according to positive or negative PWC. Recurrence-free survival and overall survival were compared between the two groups. Independent factors associated with positive PWC were investigated using multivariate analysis.
Results
Among the 284 patients analyzed, all 53 patients with ampullary carcinoma showed negative PWC and these patients were excluded. Among the remaining eligible 231 patients, 41 patients had intrahepatic cholangiocarcinoma, 55 had gall bladder carcinoma, 72 had hilar cholangiocarcinoma, and 63 had distal cholangiocarcinoma. Eleven (4.8%) patients had positive PWC, and 220 (95.2%) had negative PWC. The median recurrence-free survival in the positive and negative PWC groups were 12.0 vs. 60.7 months ( p = 0.005); the median overall survival times were 17.0 vs. 60.6 months ( p = 0.008), respectively. Multivariate analysis revealed that serum carbohydrate antigen 19–9 level over 80 U/mL and multiple lymph node metastasis were independently associated with positive PWC (odds ratio [OR]: 5.84, p = 0.031; OR: 5.28, p = 0.021, respectively).
Conclusion
Patients with positive PWC exhibited earlier recurrence and shorter survival times compared with those with negative PWC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
- Department of Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. umk@hiroshima-u.ac.jp.
- Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
- Department of Anatomical Pathology, Hiroshima University, Hiroshima, Japan.
- Digestive Disease Center, Hiroshima Memorial Hospital, Hiroshima, Japan.
Förderung
- Hiroshima University
Zitieren
APA
Sumiyoshi, T., Uemura, K., Shintakuya, R., Okada, K., Baba, K., Harada, T., Serikawa, M., Ishii, Y., Nakamura, S., Arihiro, K., Murakami, Y., & Takahashi, S. (2024). Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer. Langenbeck's Archives of Surgery. https://doi.org/10.1007/s00423-024-03233-y
Vancouver
Sumiyoshi T, Uemura K, Shintakuya R, Okada K, Baba K, Harada T, et al. Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer. Langenbeck's Archives of Surgery. 2024. doi:10.1007/s00423-024-03233-y
BibTeX
@article{Sumiyoshi2024,
author = {Sumiyoshi, Tatsuaki and Uemura, Kenichiro and Shintakuya, Ryuta and Okada, Kenjiro and Baba, Kenta and Harada, Takumi and Serikawa, Masahiro and Ishii, Yasutaka and Nakamura, Shinya and Arihiro, Koji and Murakami, Yoshiaki and Takahashi, Shinya},
title = {Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer},
journal = {Langenbeck's Archives of Surgery},
year = {2024},
doi = {10.1007/s00423-024-03233-y}
}
EUVIMED